The CPMC™ is enrolling individuals in a research study to investigate the impact of personalized medicine on health outcomes. Over the next several years, study participants will receive personalized results for their risks of complex diseases like cancer, heart disease and diabetes, as well as for their ability to metabolize certain medications. Participants will be asked to complete follow-up questionnaires to inform the medical and scientific communities about the utility of using genome information in medical care.